Boston Scientific (BSX) revenue was $20.1B in FY2025 (+20% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$20.1B
+20%
2024
$16.7B
+18%
2023
$14.2B
+12%
2022
$12.7B
+7%
2021
$11.9B
+20%
2020
$9.9B
-8%
2019
$10.7B
+9%
2018
$9.8B
+9%
2017
$9.0B
+8%
2016
$8.4B
+12%
2015
$7.5B
+0%
2014
$7.5B
+5%
2013
$7.1B
-1%
2012
$7.2B
-5%
2011
$7.6B
-2%
2010
$7.8B
-5%
2009
$8.2B
+2%
2008
$8.1B
-4%
2007
$8.4B
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$5.4B
Q1 2026
$5.2B
Q4 2025
$5.3B
Q3 2025
$5.1B
Q2 2025
$5.1B
Q1 2025
$4.7B
Q4 2024
$4.6B
Q3 2024
$4.2B
Q2 2024
$4.1B
Q1 2024
$3.9B
Q4 2023
$3.7B
Q3 2023
$3.5B
Source: BSX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.